Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 6, 2008, Pages 1281-1287

  Müller, Gerald ^a   Kramer, Axel ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Antibacterial effectiveness; In vitro; Rank ordering

Indexed keywords

ANTIINFECTIVE AGENT; BENZALKONIUM CHLORIDE; CETYLPYRIDINIUM SALT; IRGASAN; LAVASEPT; OCTENISEPT; POLY(HEXAMETHYLENEBIGUANIDE); POVIDONE IODINE; SILVER NITRATE; SILVER PROTEIN; SULFADIAZINE SILVER; TRICLOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOCOMPATIBILITY INDEX; CELL ASSAY; CELL MEDIATED CYTOTOXICITY; CULTURE MEDIUM; CYTOTOXICITY TEST; DRUG EFFICACY; DRUG SCREENING; ESCHERICHIA COLI; FIBROBLAST CULTURE; IC 50; INFRASPECIFIC RANK; NONHUMAN; SCREENING TEST; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; DRUG EVALUATION, PRECLINICAL; ESCHERICHIA COLI; FIBROBLASTS; INHIBITORY CONCENTRATION 50; MICE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; TEMPERATURE; TIME FACTORS;

EID: 44449178728     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn125     Document Type: Article

References (57)

1. Block SS. Definition of terms. In: Block SS, ed. Disinfection, Sterilization, and Preservation. Philadelphia: Lippincott Williams & Wilkins, 2001; 19-28.
2. McDonell G, Russell AD. Antiseptics and disinfectants: Activity, action, and resistance. Clin Microbiol Rev 1999; 12: 147-79.
3. Russell AD, MacDonnell G. Concentration: A major factor in studying bicidal action. J Hosp Infect 2000; 44: 1-3.
4. Schulmann G. A review of the concept of biocompatibility. Kidney Int 1993; 43 Suppl 41: S209-12.
5. Boyce S T, Holder IA. Selection of topical antimicrobial agents for cultured skin for burns by combined assessment of cytotoxicity and antimicrobial activity. Plast Reconstr Surg 1993; 92: 493-500.
6. Lineaweaver W, McMorris 8, Soucy D et al. Cellular and bacterial toxicities of topical antimicrobials. Plast Reconstr Surg 1985; 75: 394-6.
7. Alacam, T. Ömürlü H, Özkul A et al. Cytotoxicity versus antibacterial activity of some antiseptics. J Nihon Univ Sch Dent 1993; 35: 22-7.
8. Hidalgo E, Bartolome R, Dominguez C. Cytotoxicity mechanism of sodium hypochlorite in cultured dermal fibroblasts and its bactericidal effectiveness. Chem Biol Interact 2002; 139: 265-82.
9. Hobson DW, Bolsen K. Methods of testing oral and topical antiseptics and antimicrobials. In: Block SS, ed. Disinfection, Sterilization, and Preservation. Philadelphia: Lippincott Williams & Wilkins, 2001; 1329-59.
10. Campbell KE, Keast D, Woodbury G et al. Wear time in two hydrocolloid dressings using a novel in-vivo model. Wounds 2003; 15: 40-8.
11. DIN EN ISO 10993-5. Bioloqical evaluation of medical devices - part 5. Tests for cytotoxicity: in vitro methods. German version EN ISO 10993-5; 1999.
12. Fiennes AGTW, Walton J, Winterbourne D et al. Quantitative correlation of neutral red uptake with cell number in human cancer cell cultures. Cell Biol Int Rep 1987; 11: 373-8.
13. Borenfreund E, Puerner J. A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR-90). J Tissue Cult Methods 1984; 9: 7-9.
14. Borenfreund E, Puerner J. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985; 24: 119-24.
15. Wilson AP. Cytotoxicity and viability assays. In: Masters JRW, ed. Animal Cell Culture. Oxford: Oxford University Press, 2000; 175-219.
16. Edmondson JM, Armstrong LS, Martinez AO. A rapid and simple MTT-based spectrophotometric assay for determining drug sensitivity in monolayer cultures. J Tissue Cult Methods 1988; 11: 15-7.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Meth 1983; 65: 55-63.
18. DIN EN 1040. Chemical disinfectants and antiseptics - quantitative suspension test for the evaluation of basic bactericidal activity of chemical disinfectants and antiseptics - test method and requirements (phase 1). German version EN 1040; 2005.
19. Pitten F-A, Werner H-P, Kramer A. A standardized test to assess the impact of different organic challenges on the antimicrobial activity of antiseptics. J Hosp Infect 2003; 55: 108-15.
20. Sanchez IR, Nusbaum KE, Swaim SF et al. Chlorhexidine diacetate and povidone-iodine cytotoxicity to canine embryonic fibroblasts and Staphylococcus aureus. Vet Surg 1988; 17: 182-5.
21. McCauley RL, Linares HA, Pelligrini V et al. In vitro toxicity of topical antimicrobial agents to human fibroblasts. J Surg Res 1989; 46: 267-74.
22. Ponec M, Haverkort M, Soei YL et al. Use of human keratinocyte and fibroblast cultures for toxicity studies of topically applied compounds. J Pharm Sci 1990; 79: 312-6.
23. Cooper ML, Boyce ST, Hansbrough JF et al. Cytotoxicity to cultured human keratinocytes of topical antimicrobial agents. J Surg Res 1990; 48: 190-5.
24. Cooper ML, Laxer JA, Hansbrough JF. The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J Trauma 1991; 31: 775-84.
25. Damour O, Hua SZ, Lasne F et al. Cytotoxicity evaluation of antiseptics and antibiotics on cultured human fibroblasts and keratinocytes. Burns 1992; 18: 479-85.
26. Teepe RGC, Koebrugge EJ, Löwik CWGM et al. Cytotoxic effects of topical antimicrobial and antiseptic agents on human keratinocytes in vitro. J Trauma 1993; 35: 8-19.
27. Boyce ST, Warden GD, Holder IA. Cytotoxicity testing of topical antimicrobial agents on human keratinocytes and fibroblasts for cultured skin grafts. J Burn Care Rehabil 1995; 16: 97-103.
28. Gilbert P, Moore LE. Cationic antiseptics: Diversity of action under a common epithet. J Appl Microbiol 2005; 99: 703-15.
29. Clement JL, Jarrett PS. Antibacterial silver. Met Based Drugs 1994; 1: 467-82.
30. Russell AD, Hugo WB. Antimicrobial activity and action of silver. Prog Med Chem 1994; 31: 351-70.
31. Hidalgo E, Bartolome R, Barroso C et al. Silver nitrate: antimicrobial activity related to cytotoxicity in cultured human fibroblast. Skin Pharmacol Appl Skin Physiol 1998; 11: 140-51.
32. Lansdown ABG. Silver I: Its antibacterial properties mechanism of action. J Wound Care 2002; 11: 125-30.
33. Müller G, Winkler Y, Kramer A. Antibacterial activity and endotoxin-binding capacity of Actisorb® Silver 220. J Hosp Infect 2003; 53: 211-4.
34. Lansdown ABG. Silver absorption and antibacterial efficacy of silver dressings. J Wound Care 2005; 14: 155-60.
35. Thomas S, McCubbin P. A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J Wound Care 2003; 12: 101-7.
36. Thomas S, McCubbin P. An in vitro analysis of the antimicrobial properties of 10 silver-containing dressings. J Wound Care 2003; 12: 305-8.
37. Poon VKM, Burd A. In vitro cytotoxicity of silver: Implications for clinical wound care. Burns 2004; 30: 140-7.
38. Hollinger MA. Toxicological aspects of topical silver pharmaceuticals. Crit Rev Toxicol 1996; 26: 255-60.
39. Wilson JR, Mills JG, Prather ID et al. A toxicity index of skin and wound cleansers used in vitro fibroblasts and keratinocytes. Adv Skin Wound Care 2005; 18: 373-8.
40. Güzelsagaltici N, Girgin S, Gedik E et al. Intraperitoneal octenidindihydro-chloride - phenoxyethanol solution to prevent peritoneal adhesion formation in a rat peritonitis model. Acta Obstet Gynecol 2007; 86: 395-400.
41. Emilson CG, Bowen WH, Robrish SA et al. Effect of the antibacterial agents octenidine and chlorhexidine on the plaque flora in primates. Scand J Dent Res 1981; 89: 384-92.
42. Robrish SA, Emilson C-G, Kemp CW et al. A comparison of viable counts and adenine nucleotide analysis to determine the effect of antimicrobial agents on dental plaque. Curr Microbiol 1981; 5 343-7.
43. Slee AM, O'Connor JR. In vitro antiplaque activity of octenidine dihydrochloride (WIN 41464-2) against preformed plaques of selected oral plaque-forming microorganisms. Antimicrob Agents Chemother 1983; 23: 379-84.
44. Kramer A, Höppe H, Krull B et al. Antiseptic efficacy and acceptance of Octenisept® compared to common antiseptic mouthwash solutions. Int J Hyg Environ Med 1998: 200: 443-56.
45. Kramer A, Roth B, Müller G et al. Influence of the antiseptic agents polihexanide and octenidine on FL-cells and on healing of experimental superficial aseptic wounds in piglets. A double-blind, randomised, stratified controlled, parallel-group study. Skin Pharmacol Physiol 2004; 17: 141-6.
46. Mulder GD, Cavorsi JP, Lee DK. Feature: Polyhexamethylene biguanide (PHMB): An addendum to current topical antimicrobials. Wounds 2007; 19: 173-82.
47. Wiegand C, Abel M, Kramer A et al. Stimulation of proliferation and biocompatibility of polihexanide. GMS Krankenhaushyg Interdiszip 2007; 2: Doc43 (20071228).
48. Schmit-Neuerburg KP, Bettag G, Schlickewei W et al. Effectiveness of an improved antiseptic in treatment of contaminated soft tissue wounds. Chirurg 2001; 72: 61-71.
49. Daeschlein G, Assadian O, Bruck JC et al. Feasibility and clinical applicability of polihexanide for treatment of second-degree burn wounds. Skin Pharmacol Physiol 2007; 20: 292-6.
50. Innes ME. The use of silver coated dressings on donor site wounds: A prospective, controlled matched pair study. Burns 2001; 27: 621-7.
51. Atiyeh BS, Costagliola M, Hayek SN et al. Effect of silver on burn wound infection control and healing: Review of the literature. Burns 2007; 33: 139-48.
52. Vermeulen H, van Hattem JM, Storm-Versloot MN et al. Topical silver for treatinq infected wounds. Cochrane Database Syst Rev 2007; 1: CD005486.
53. Silver S. Bacterial silver resistance: Molecular biology and misuses of silver compounds. FEMS Microbiol Rev 2003; 27: 341-53.
54. Percival SL, Bowler PG, Russell D. Bacterial resistance to silver in wound care. J Hosp Infect 2005; 60: 1-7.
55. Bassetti C, Kallenberqer A. Influence of chlorhexidine rinsing on the healing of oral mucosa and osseous lesions. J Clin Periodontol 1980; 7: 443-56.
56. Paunio KU, Knuuttila M, Miellityinen H. The effect of chlorhexidine gluconate on the formation of experimental granulation tissue. J Periodontol 1978; 49: 92-5.
57. Reimer K, Vogt PM, Broegmann B et al. An innovative topical drug formulation for wound healing and infection treatment: in vitro and in vivo investigations of a povidone-iodine liposome hydrogel. Dermatology 2000; 201: 235-41.